Pervenio Lung RS from Life Technologies

[News]

Life Technologies Corporation today announced the launch of Pervenio Lung RS. First-of-its-kind, the molecular test has been documented to reliably identify early stage lung cancer patients who are at high risk for mortality following surgery. It also fulfills an unmet need for prognostic information to guide preventative treatment and improve disease management.

More... (http://www.news-medical.net/news/20120925/Pervenio-Lung-RS-from-Life-Technologies.aspx)